Selected research
Market Structure
Global GERD Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global GERD market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for GERD is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of GERD include Takeda, Eisai, Johnson & Johnson, GlaxoSmithKline and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global GERD market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GERD and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GERD sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the GERD market size, projected growth trends, production technologies, key applications, and end-use industries.
GERD Segment by Company
Takeda
Eisai
Johnson & Johnson
GlaxoSmithKline
AstraZeneca
GERD Segment by Type
CAM
H2 Receptor Antagonists
Prokinetics
Antacids
Proton Pumps Inhibitors
GERD Segment by Application
Hospital Pharmacy
Drug Stores
Supermarkets
General Stores
GERD Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GERD market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GERD and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GERD.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the GERD market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GERD manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of GERD in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of GERD in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- CAM
- H2 Receptor Antagonists
- Prokinetics
- Antacids
- Proton Pumps Inhibitors
Applications
- Hospital Pharmacy
- Drug Stores
- Supermarkets
- General Stores
Companies covered
- Takeda
- Eisai
- Johnson & Johnson
- GlaxoSmithKline
- AstraZeneca
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global GERD Market Size, 2021 VS 2025 VS 2032
- 1.3 Global GERD Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global GERD Sales Estimates and Forecasts (2021-2032)
- 1.5 Global GERD Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global GERD Market Dynamics
- 2.1 GERD Industry Trends
- 2.2 GERD Industry Drivers
- 2.3 GERD Industry Opportunities and Challenges
- 2.4 GERD Industry Restraints
3 GERD Market by Manufacturers
- 3.1 Global GERD Revenue by Manufacturers (2021-2026)
- 3.2 Global GERD Sales by Manufacturers (2021-2026)
- 3.3 Global GERD Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global GERD Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global GERD Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global GERD Manufacturers, Product Type & Application
- 3.7 Global GERD Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global GERD Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 GERD Players Market Share by Revenue in 2025
- 3.8.3 2025 GERD Tier 1, Tier 2, and Tier 3
4 GERD Market by Type
- 4.1 GERD Type Introduction
- 4.1.1 CAM
- 4.1.2 H2 Receptor Antagonists
- 4.1.3 Prokinetics
- 4.1.4 Antacids
- 4.1.5 Proton Pumps Inhibitors
- 4.2 Global GERD Sales by Type
- 4.2.1 Global GERD Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global GERD Sales by Type (2021-2032)
- 4.2.3 Global GERD Sales Market Share by Type (2021-2032)
- 4.3 Global GERD Revenue by Type
- 4.3.1 Global GERD Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global GERD Revenue by Type (2021-2032)
- 4.3.3 Global GERD Revenue Market Share by Type (2021-2032)
5 GERD Market by Application
- 5.1 GERD Application Introduction
- 5.1.1 Hospital Pharmacy
- 5.1.2 Drug Stores
- 5.1.3 Supermarkets
- 5.1.4 General Stores
- 5.2 Global GERD Sales by Application
- 5.2.1 Global GERD Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global GERD Sales by Application (2021-2032)
- 5.2.3 Global GERD Sales Market Share by Application (2021-2032)
- 5.3 Global GERD Revenue by Application
- 5.3.1 Global GERD Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global GERD Revenue by Application (2021-2032)
- 5.3.3 Global GERD Revenue Market Share by Application (2021-2032)
6 Global GERD Sales by Region
- 6.1 Global GERD Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global GERD Sales by Region (2021-2032)
- 6.2.1 Global GERD Sales by Region (2021-2026)
- 6.2.2 Global GERD Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America GERD Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America GERD Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe GERD Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe GERD Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific GERD Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific GERD Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa GERD Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa GERD Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global GERD Revenue by Region
- 7.1 Global GERD Revenue by Region
- 7.1.1 Global GERD Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global GERD Revenue by Region (2021-2026)
- 7.1.3 Global GERD Revenue by Region (2027-2032)
- 7.1.4 Global GERD Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America GERD Revenue (2021-2032)
- 7.2.2 North America GERD Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe GERD Revenue (2021-2032)
- 7.3.2 Europe GERD Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific GERD Revenue (2021-2032)
- 7.4.2 Asia-Pacific GERD Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa GERD Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa GERD Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Takeda
- 8.1.1 Takeda Company Information
- 8.1.2 Takeda Business Overview
- 8.1.3 Takeda GERD Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Takeda GERD Product Portfolio
- 8.1.5 Takeda Recent Developments
- 8.2 Eisai
- 8.2.1 Eisai Company Information
- 8.2.2 Eisai Business Overview
- 8.2.3 Eisai GERD Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Eisai GERD Product Portfolio
- 8.2.5 Eisai Recent Developments
- 8.3 Johnson & Johnson
- 8.3.1 Johnson & Johnson Company Information
- 8.3.2 Johnson & Johnson Business Overview
- 8.3.3 Johnson & Johnson GERD Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Johnson & Johnson GERD Product Portfolio
- 8.3.5 Johnson & Johnson Recent Developments
- 8.4 GlaxoSmithKline
- 8.4.1 GlaxoSmithKline Company Information
- 8.4.2 GlaxoSmithKline Business Overview
- 8.4.3 GlaxoSmithKline GERD Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline GERD Product Portfolio
- 8.4.5 GlaxoSmithKline Recent Developments
- 8.5 AstraZeneca
- 8.5.1 AstraZeneca Company Information
- 8.5.2 AstraZeneca Business Overview
- 8.5.3 AstraZeneca GERD Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 AstraZeneca GERD Product Portfolio
- 8.5.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 GERD Value Chain Analysis
- 9.1.1 GERD Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 GERD Production Mode & Process
- 9.2 GERD Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 GERD Distributors
- 9.2.3 GERD Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst